No connection

Search Results

KIDZ vs RKDA

KIDZ
Classover Holdings, Inc.
BEARISH
Price
$2.31
Market Cap
$3.0M
Sector
Consumer Defensive
AI Confidence
95%
RKDA
Arcadia Biosciences, Inc.
BEARISH
Price
$1.18
Market Cap
$2.4M
Sector
Consumer Defensive
AI Confidence
95%

Valuation

P/E Ratio
KIDZ
--
RKDA
--
Forward P/E
KIDZ
--
RKDA
-0.92
P/B Ratio
KIDZ
0.21
RKDA
0.39
P/S Ratio
KIDZ
0.9
RKDA
0.5
EV/EBITDA
KIDZ
-3.0
RKDA
0.41

Profitability

Gross Margin
KIDZ
56.97%
RKDA
36.04%
Operating Margin
KIDZ
-184.66%
RKDA
-152.61%
Profit Margin
KIDZ
-209.27%
RKDA
-48.15%
ROE
KIDZ
--
RKDA
-45.14%
ROA
KIDZ
-25.82%
RKDA
-32.71%

Growth

Revenue Growth
KIDZ
-38.3%
RKDA
-25.9%
Earnings Growth
KIDZ
--
RKDA
--

Financial Health

Debt/Equity
KIDZ
2.5
RKDA
--
Current Ratio
KIDZ
1.21
RKDA
3.09
Quick Ratio
KIDZ
1.21
RKDA
2.42

Dividends

Dividend Yield
KIDZ
--
RKDA
--
Payout Ratio
KIDZ
0.0%
RKDA
0.0%

AI Verdict

KIDZ BEARISH

KIDZ exhibits extreme financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is in a state of collapse, evidenced by a 97.5% one-year price decline and a catastrophic drop from a 52-week high of $532.50 to $2.31. With revenue shrinking by 38.3% YoY and profit margins at -209.27%, the business model is currently unsustainable. Despite a low Price-to-Book ratio of 0.21, the high Debt/Equity ratio of 2.50 and lack of positive cash flow suggest a high risk of insolvency.

Strengths
Positive Gross Margin (56.97%)
Current Ratio above 1.0 (1.21)
Trading significantly below book value (P/B 0.21)
Risks
Severe revenue contraction (-38.3% YoY)
Extreme operating losses (Operating Margin -184.66%)
High leverage with Debt/Equity at 2.50
RKDA BEARISH

RKDA exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental improvement across all health metrics. Despite a strong current ratio of 3.09 suggesting short-term liquidity, the company suffers from severe operational inefficiency with an operating margin of -152.61% and declining year-over-year revenue growth of -25.90%. The catastrophic 5-year price decline of -98.8% and a 0/100 technical trend score confirm a persistent bearish trajectory. The stock is currently a classic value trap, trading at a low Price/Book (0.39) but lacking any catalyst for recovery.

Strengths
Strong short-term liquidity (Current Ratio: 3.09)
Positive Gross Margin (36.04%) indicating product viability
Low Price-to-Book ratio (0.39) suggesting deep discount to assets
Risks
Critical fundamental health (Piotroski F-Score: 0/9)
Severe operational losses (Operating Margin: -152.61%)
Negative revenue growth (-25.90% YoY)

Compare Another Pair

KIDZ vs RKDA: Head-to-Head Comparison

This page compares Classover Holdings, Inc. (KIDZ) and Arcadia Biosciences, Inc. (RKDA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile